Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06443385 · ClinicalTrials.gov registry record · NA
E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs
A NA study of Opioid Prescribing and Prescription Drug Misuse, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 7,872
- Enrollment target
- 1
- Study location
NCT06443385: Completed NA study of Opioid Prescribing and Prescription Drug Misuse, sponsored by Columbia University.
NCT06443385 is a NA study of Opioid Prescribing and Prescription Drug Misuse that has completed, run by Columbia University. The registered enrollment target is 7,872 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (461% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06443385, a NA study of Opioid Prescribing and Prescription Drug Misuse, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,872 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test e-mails to encourage engagement with the Minnesota prescription monitoring program (PMP/PDMP) and will evaluate the effect of these e-mails on PMP/PDMP use and controlled substance prescribing.
Primary Outcome
An indicator for increased PDMP engagement during the 2-month period after the first e-mails were sent. It will indicate whether the level of engagement rose from the baseline level that resulted in the clinician's enrollment into the study. For clinicians who lacked an account, the outcome will indicate whether they created one; for clinicians with an inactive account, the outcome will indicate whether they reactivated it. For those who never searched, it will indicate any search, and for those
Conditions Studied
Interventions
- BEHAVIORAL PDMP Legal Mandate E-mail
- BEHAVIORAL PDMP Clinical Benefit E-mail
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,872 participants |
| Start Date | 2024-07-17 |
| Est. Completion | 2025-09-24 |
| Phase | NA |
What the finished NCT06443385 record still lists
NCT06443385 is an interventional study that assigns participants to a tested intervention. Its 7,872 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (461% higher).
The record links to 2 conditions, with Opioid Prescribing appearing as the primary indexed condition, and to 2 interventions - of which PDMP Legal Mandate E-mail is the first listed.
NCT06443385 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06443385 about?
NCT06443385 is a clinical study titled "E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs". This study will test e-mails to encourage engagement with the Minnesota prescription monitoring program (PMP/PDMP) and will evaluate the effect of these e-mails on PMP/PDMP use and controlled substance prescribing.
What is the current status of trial NCT06443385?
This trial is currently completed. It is a NA study. The enrollment target is 7,872 participants. The study started on 2024-07-17. Estimated completion is 2025-09-24.
What conditions does trial NCT06443385 study?
This clinical trial studies the following conditions: Opioid Prescribing, Prescription Drug Misuse.
What interventions are being tested in trial NCT06443385?
The interventions under investigation include: PDMP Legal Mandate E-mail (BEHAVIORAL), PDMP Clinical Benefit E-mail (BEHAVIORAL).
Who is sponsoring clinical trial NCT06443385?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06443385 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Prescribing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06443385's enrollment target sits among peer trials
7,872 20th of 2000 higher than 1,981 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI